×
Back to Agenda
TOPIC 5 SESSION 5: Effectiveness of Risk Minimisation Measures
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Jan Petracek, MD, MSC
CEO, iVigee Services a.s., Czech Republic
Effectiveness of Risk Minimisation Measures
Have an account?